"Troy Brown, RN
Medscape Medical News
Clostridium difficile caused nearly half a million infections and was associated with about 29,000 deaths in 2011, according to new data released today by the Centers for Disease Control "...
(pancrelipase, USP) Tablets, Powder
VIOKASE® (pancrelipase, USP) is a pancreatic enzyme concentrate of porcine origin containing standardized lipase, protease, and amylase as well as other pancreatic enzymes. VIOKASE® (pancrelipase tablets, powder) is available in tablet and powder dosage form for oral administration.
The enzyme potencies of the tablets and powder are:
| VIOKASE® Powder
Each 0.7 g (1/4 Teaspoonful)
|Lipase, USP units||8,000||16,000||16,800|
|Protease, USP units||30,000||60,000||70,000|
|Amylase, USP units||30,000||60,000||70,000|
Inactive Ingredients: VIOKASE® (pancrelipase tablets, powder) 8 and VIOKASE® (pancrelipase tablets, powder) 16 Tablets: Lactose, croscarmellose sodium, microcrystalline cellulose, silicon dioxide, stearic acid, talc. VIOKASE® (pancrelipase tablets, powder) Powder: Lactose, sodium chloride.
What are the possible side effects of pancrelipase?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have severe or unusual stomach pain. This could be a symptom of a rare but serious bowel disorder.
Less serious side effects may include:
- nausea or vomiting;
- mild stomach pain or upset;
- diarrhea or constipation;
- bloating or gas;
- greasy stools;
- rectal irritation;
- headache, dizziness;
- cough; or
Last reviewed on RxList: 12/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Viokase Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.